SEC Company Response from NANOVIRICIDES, (NNVC) — Dec 18, 2025
NANOVIRICIDES, INC.
Date: Dec. 18, 2025 · CIK: 0001379006 · Accession: 0001104659-25-122405
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292142
Letter
Re: NanoViricides, Inc.
December 18, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Crypto Assets
100 F Street, N.E.
Washington, DC 20549
Registration Statement on Form S-3, File No. 333-292142
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Requested Date: December 19, 2025
Requested Time: 4:30 pm, Eastern Time
Ladies and Gentlemen:
NanoViricides, Inc. (the "Company") hereby requests that the effective date of the Company's Registration Statement on Form S-3, as amended (File No. 333-292142), be accelerated pursuant to Rule 461 under the Securities Act of 1933, as amended, so that it is declared and becomes effective at 4:30 pm Eastern Time on December 19, 2025, or as soon thereafter as possible.
Please contact our counsel Peter Campitiello of Lucosky Brookman LLP at (732) 395-4517 with any questions you may have regarding this request. In addition, the Company requests that you kindly notify Mr. Campitiello by telephone when this request for acceleration has been granted.
Sincerely yours,
NANOVIRICIDES, INC.
Show Raw Text
CORRESP 1 filename1.htm December 18, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Crypto Assets 100 F Street, N.E. Washington, DC 20549 Re: NanoViricides, Inc. Registration Statement on Form S-3, File No. 333-292142 REQUEST FOR ACCELERATION OF EFFECTIVENESS Requested Date: December 19, 2025 Requested Time: 4:30 pm, Eastern Time Ladies and Gentlemen: NanoViricides, Inc. (the "Company") hereby requests that the effective date of the Company's Registration Statement on Form S-3, as amended (File No. 333-292142), be accelerated pursuant to Rule 461 under the Securities Act of 1933, as amended, so that it is declared and becomes effective at 4:30 pm Eastern Time on December 19, 2025, or as soon thereafter as possible. Please contact our counsel Peter Campitiello of Lucosky Brookman LLP at (732) 395-4517 with any questions you may have regarding this request. In addition, the Company requests that you kindly notify Mr. Campitiello by telephone when this request for acceleration has been granted. Sincerely yours, NANOVIRICIDES, INC. /s/ Anil Diwan Anil Diwan President